AU2001275231A1 - Method of preparing salicylamides - Google Patents

Method of preparing salicylamides

Info

Publication number
AU2001275231A1
AU2001275231A1 AU2001275231A AU7523101A AU2001275231A1 AU 2001275231 A1 AU2001275231 A1 AU 2001275231A1 AU 2001275231 A AU2001275231 A AU 2001275231A AU 7523101 A AU7523101 A AU 7523101A AU 2001275231 A1 AU2001275231 A1 AU 2001275231A1
Authority
AU
Australia
Prior art keywords
salicylamides
preparing
preparing salicylamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275231A
Inventor
William E. Bay
Joanne P. Corvino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emisphere Technologies Inc
Original Assignee
Emisphere Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Technologies Inc filed Critical Emisphere Technologies Inc
Publication of AU2001275231A1 publication Critical patent/AU2001275231A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
AU2001275231A 2000-06-02 2001-06-04 Method of preparing salicylamides Abandoned AU2001275231A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20903900P 2000-06-02 2000-06-02
US60209039 2000-06-02
PCT/US2001/018118 WO2001092206A1 (en) 2000-06-02 2001-06-04 Method of preparing salicylamides

Publications (1)

Publication Number Publication Date
AU2001275231A1 true AU2001275231A1 (en) 2001-12-11

Family

ID=22777068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275231A Abandoned AU2001275231A1 (en) 2000-06-02 2001-06-04 Method of preparing salicylamides

Country Status (3)

Country Link
US (1) US7262325B2 (en)
AU (1) AU2001275231A1 (en)
WO (1) WO2001092206A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126318A (en) 1996-03-29 2004-09-27 Emisphere Tech Inc Compounds and compositions for delivering active agents and some novel carrier compounds
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin
RU2006138703A (en) 2004-05-06 2008-06-20 Эмисфире Текнолоджис SOLID MEDICINAL FORM OF HUMIDIFIED HEPARIN
MXPA06013252A (en) 2004-05-14 2007-02-28 Emisphere Tech Inc Compounds and compositions for delivering active agents.
AU2005244986B2 (en) 2004-05-19 2011-01-27 Emisphere Technologies, Inc. Topical cromolyn formulations
WO2005112937A1 (en) 2004-05-19 2005-12-01 Emisphere Technologies, Inc. Acyclovir formulations
GB0427603D0 (en) 2004-12-16 2005-01-19 Novartis Ag Organic compounds
AU2005321803B2 (en) 2004-12-29 2012-02-09 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US8771712B2 (en) 2006-05-09 2014-07-08 Emisphere Technologies, Inc. Topical administration of acyclovir
US8426466B2 (en) 2006-05-22 2013-04-23 Nexus Pharma, Inc. Compositions and methods for enhancing active agent absorption
US9364502B2 (en) 2006-06-28 2016-06-14 Emisphere Technologies, Inc. Gallium nitrate formulations
CA2662853C (en) * 2006-08-31 2016-07-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2662080C (en) 2006-09-07 2012-07-17 F. Hoffmann-La Roche Ag A process for the manufacture of snac (salcaprozate sodium)
JP5985985B2 (en) 2009-08-03 2016-09-06 エミスフィアー テクノロジーズ インコーポレイテッドＥｍｉｓｐｈｅｒｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． Rapid-acting naproxen composition with reduced gastrointestinal effects
SI2651398T1 (en) 2010-12-16 2018-04-30 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
EP3542790B1 (en) 2012-03-22 2023-09-13 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
ES2690553T3 (en) 2012-03-22 2018-11-21 Novo Nordisk A/S GLP-1 peptide compositions and preparation of these
PT2991671T (en) 2013-05-02 2018-11-05 Novo Nordisk As Oral dosing of glp-1 compounds
WO2017092034A1 (en) * 2015-12-04 2017-06-08 深圳市广昌达实业有限公司 Method for synthesizing gasoline additive alkyl formamide phenyl ether
CN105461590A (en) * 2015-12-31 2016-04-06 镇江高鹏药业有限公司 Preparation method of energy-saving environment-friendly salicylamide
TWI797133B (en) 2017-06-09 2023-04-01 丹麥商諾佛 儂迪克股份有限公司 Solid compositions for oral administration
WO2019149880A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant
TWI829687B (en) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US20220323544A1 (en) 2019-08-07 2022-10-13 Novo Nordisk A/S Solid compositions comprising an egf(a) derivative and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
JP2022547094A (en) 2019-09-06 2022-11-10 ノヴォ ノルディスク アー／エス Method and apparatus for fractionation of granules for use in pharmaceutical compositions
EP4054620A1 (en) 2019-11-06 2022-09-14 Novo Nordisk A/S Glp-1 receptor agonists in dementia
KR20220112751A (en) 2019-11-07 2022-08-11 노보 노르디스크 에이/에스 A solid composition comprising a PCSK9 inhibitor and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
EP4054536A1 (en) 2019-11-07 2022-09-14 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, an sglt2 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
US11478533B2 (en) 2020-04-27 2022-10-25 Novo Nordisk A/S Semaglutide for use in medicine
EP4142695A1 (en) 2020-04-29 2023-03-08 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist and histidine
EP4323330A1 (en) 2021-04-16 2024-02-21 Navinta III Inc Process for the preparation of highly pure salcaprozic acid and pharmaceutically acceptable salts thereof
US11667614B2 (en) 2021-04-16 2023-06-06 Navinta III Inc. Process for the preparation of highly pure Salcaprozic Acid and pharmaceutically acceptable salts thereof
WO2022268213A1 (en) 2021-06-25 2022-12-29 甘李药业股份有限公司 Pharmaceutical composition containing glp-1 compound
IL309535A (en) 2021-07-15 2024-02-01 Novo Nordisk As Tablet comprising a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
WO2023012263A1 (en) 2021-08-04 2023-02-09 Novo Nordisk A/S Solid oral peptide formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2835668A (en) 1956-06-22 1958-05-20 Us Vitamin Corp Pyridylethylated benzoxazinediones and process for preparation
GB1069367A (en) 1964-10-01 1967-05-17 Aspro Nicholas Ltd Improvements in or relating to the production of 1:3-benzoxazine-2:4-dione
US3907893A (en) * 1974-06-28 1975-09-23 Goodyear Tire & Rubber Preparation of antioxidant amides
US4379928A (en) * 1981-03-04 1983-04-12 Union Carbide Corporation Synthesis of amides
DE3633501A1 (en) 1986-10-02 1988-04-14 Henkel Kgaa USE OF SALYCILE ACID AMIDES AS AN ANTIMICROBIAL ACTIVE SUBSTANCES
US5442092A (en) 1994-04-04 1995-08-15 Jame Fine Chemicals, Inc. Preparation of esters of 3,5,6-trichlorosalicyclic acid
US6084112A (en) 1995-09-11 2000-07-04 Emisphere Technologies, Inc. Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones
US5773647A (en) * 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9916669A (en) 1998-12-30 2001-10-16 Bayer Ag Use of derivatives of substituted 4-biarylbutyric and 5-biarylpentanoic acids as matrix metalloprotease inhibitors for the treatment of respiratory diseases
EP1149066B1 (en) 1999-02-05 2005-11-09 Emisphere Technologies, Inc. Method of preparing alkylated salicylamides
ATE554062T1 (en) 2000-03-21 2012-05-15 Emisphere Tech Inc METHOD FOR PRODUCING ALKYLATED SALICYLAMEDES BY A DICARBOXYLATE INTERMEDIATE

Also Published As

Publication number Publication date
US20030216593A1 (en) 2003-11-20
US7262325B2 (en) 2007-08-28
WO2001092206A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
AU2001275231A1 (en) Method of preparing salicylamides
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU6397301A (en) Synchronization method
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
AU3867400A (en) Methods of using bioelastomers
AU2001281493A1 (en) Method of preparing a polymerizate
AU2001294549A1 (en) Process and intermediates
AU2000276782A1 (en) Spray-spin coating method
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001257297A1 (en) Method of authenticating user
AU2000265991A1 (en) Novel method of preparing p-phenylenediamine
AU7964600A (en) Production method of radiators
AU2002231683A1 (en) Method of producing alk-3-ene-1-ols
AU2001272368A1 (en) Method for the preparation of citalopram
AU2728901A (en) Method of making hydrofluorocarbons
AUPQ904100A0 (en) Method of encryption
AU2001237530A1 (en) Method
AU2001241636A1 (en) Halotherapy method
AU2001234472A1 (en) Method of preparing compounds using cavitation and compounds formed therefrom
AU2002222927A1 (en) Method of making hydrofluorocarbons
AUPQ639300A0 (en) Method of enhancing or maintaining a relationship
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
AU2001249776A1 (en) Method of polycarbonate preparation
AU1478201A (en) Improved method of immunization
AU2001286268A1 (en) Method of forming complex